Australian Personal Products Stock News

PLS Group (ASX:PLS) has reported its H1 2026 result with trailing twelve month revenue of A$966.9 million and a net income loss of A$93.8 million, against a backdrop where recent halves have ranged from A$343.2 million to A$496.9 million in revenue and swung from a profit of A$36.7 million to a loss of A$126.4 million. The company has seen revenue move from A$496.9 million in H2 2024 to A$425.7 million in H1 2025 and A$343.2 million in H2 2025, while EPS shifted from A$0.012 in H2 2024 to...

Wesfarmers Limited has reported past half-year results to 31 December 2025, with sales rising to A$24,212 million and net income to A$1,603 million, alongside higher basic earnings per share from continuing operations of A$1.414. Alongside the stronger headline numbers, management warned of uneven consumer spending and outlined plans for price cuts funded by productivity gains, including greater use of artificial intelligence. With these results in hand, we’ll now examine how stronger...

Commonwealth Bank of Australia (ASX:CBA) has put fresh earnings and income on the table, pairing higher half year net profit with an estimated fully franked interim dividend of A$2.35 per share for eligible shareholders. See our latest analysis for Commonwealth Bank of Australia. At a share price of A$178.19, Commonwealth Bank of Australia has seen strong short term momentum with a 30 day share price return of 18.41% and a 90 day gain of 16.42%. The 1 year total shareholder return of 17.74%...

Iluka Resources FY 2025 earnings snapshot Iluka Resources (ASX:ILU) has capped FY 2025 with a mixed set of numbers, as second half revenue came in at A$437.6 million alongside a basic EPS loss of A$0.89, following a profitable first half. The company has seen revenue shift from A$540.6 million and EPS of A$0.23 in 2H 2024 to A$577.8 million and EPS of A$0.22 in 1H 2025, before landing at A$437.6 million with a loss in 2H 2025. This puts the focus squarely on how sustainably Iluka can convert...

Hearts and Minds Investments (ASX:HM1) has posted its H1 2026 numbers with trailing twelve month revenue of A$43.3 million and basic EPS of A$0.08, while the latest reported half year in H2 2025 showed revenue of A$28.1 million and basic EPS of A$0.06. This keeps the focus firmly on how much profit it is converting from its investment portfolio. Over recent reporting periods the company has seen revenue move from A$57.7 million in H2 2024 to A$133.6 million in H1 2025 and A$28.1 million in H2...

Austco Healthcare (ASX:AHC) has reported a solid set of H1 2026 numbers, with revenue of A$48.2 million and net income of A$4.7 million translating to basic EPS of A$0.0128 as the company updates the market on its latest half year. Over the past three reported halves, revenue has moved from A$36.9 million in H1 2025 to A$44.5 million in H2 2025 and now A$48.2 million, while basic EPS has shifted from A$0.0081 to A$0.0082 and now A$0.0128. Together, these figures give investors clearer...

When companies post strong earnings, the stock generally performs well, just like Viva Leisure Limited's ( ASX:VVA...

Pepper Money (ASX:PPM) has put fresh numbers on the table for FY 2025, with first half revenue of A$187.4 million, basic EPS of A$0.106, and net income of A$47 million setting the tone against a trailing 12 month revenue base of A$396.5 million and EPS of A$0.236. The company has seen revenue move from A$186.1 million and basic EPS of A$0.106 in the first half of 2024 to A$200.8 million and A$0.118 in the second half of 2024, while trailing 12 month net income has tracked at A$104.6 million...

Transurban Group (ASX:TCL) has just posted its H1 2026 scorecard, with revenue of A$1.9 billion and basic EPS of A$0.06, while trailing twelve month figures show revenue of A$3.9 billion and basic EPS of A$0.15, as earnings growth over the past year has been very large and margins have moved to 12.2% from 2%. The company has seen revenue shift from A$2.0 billion in H2 2024 to A$1.8 billion in H1 2025 and A$1.9 billion in H2 2025, with basic EPS moving from A$0.04 to a loss of A$0.02 and then...

Redox (ASX:RDX) has put fresh numbers on the board for H1 2026, with trailing 12 month revenue of A$1.29b and net income of A$81.0 million framing the latest set of results. Prior half year snapshots show revenue at A$631.8 million with EPS of A$0.076 in H1 2025, A$611.9 million with EPS of A$0.070 in H2 2025, and A$555.4 million with EPS of A$0.097 in H2 2024. Over those periods, the data tracks a revenue step up from A$555.4 million in H2 2024 to A$631.8 million in H1 2025, alongside shifts...

As the Australian market navigates a busy reporting season with major companies like Rio Tinto and Telstra sharing their results, the ASX is poised for growth, buoyed by gains in U.S. tech stocks despite ongoing concerns about inflation. In this context, identifying growth companies with high insider ownership can be particularly appealing to investors seeking stability and confidence in management's commitment to long-term success.

As the Australian market navigates a busy reporting season, bolstered by gains in tech stocks and fluctuating commodity prices, investors are keenly watching the ASX for signs of stability and growth. In this environment, identifying stocks with strong fundamentals becomes crucial, as they offer resilience amid economic shifts and sector-specific developments.

The Australian market is experiencing a busy reporting day, with significant activity from blue-chip companies and a positive influence from tech stock rebounds in the U.S. For investors interested in smaller or newer companies, penny stocks—despite their somewhat outdated name—remain an intriguing investment area. These stocks can offer growth potential at lower price points when backed by strong financials and solid fundamentals.

Australian United Investment (ASX:AUI) has laid out a steady set of numbers for H1 2026, with total revenue of A$28.0 million and basic EPS of A$0.20 anchoring the latest result. The company has seen revenue move from A$29.4 million in H2 2024 to A$29.0 million in H1 2025 and A$28.0 million in H2 2025, while basic EPS has tracked around A$0.20 across those periods, giving investors a relatively consistent earnings line to work with. With net profit margins sitting at very high levels on a...

Genesis Minerals (ASX:GMD) has reported a busy set of H1 2026 numbers, with total revenue for the latest half at A$581.4 million and basic EPS of A$0.15, compared with a trailing 12 month profile that shows A$1.4 billion of revenue and basic EPS of A$0.36. The company’s revenue has moved from A$222.7 million and EPS of A$0.07 in H2 2024 to A$338.7 million and EPS of A$0.05 in H1 2025, then to A$581.4 million and EPS of A$0.15 in H2 2025. This sets up H1 2026 as another data point in a rapidly...

Bega Cheese (ASX:BGA) has just posted its H1 2026 scorecard, with trailing 12‑month revenue at about A$3.6b and Basic EPS of A$0.03, set against a recent half year that included a one off loss of A$38.2m. Over recent halves, the company has seen revenue move from A$1.79b in H2 2024 to A$1.78b in H1 2025 and A$1.76b in H2 2025, while Basic EPS shifted from A$0.01 in H2 2024 to A$0.10 in H1 2025 and a loss of A$0.13 in H2 2025. This has left investors focused on how quickly margins can rebuild...

Telstra Group (ASX:TLS) has released its H1 2026 scorecard with trailing 12 month revenue of A$23.1 billion and basic EPS of A$0.20, setting a clear benchmark for how the telco is converting its scale into earnings. Over recent periods, the company has seen revenue move from A$11.5 billion in H2 2024 to A$11.6 billion in H1 2025 and A$11.5 billion in H2 2025, while basic EPS shifted from A$0.06 in H2 2024 to A$0.09 in H1 2025 and A$0.10 in H2 2025, giving investors a consistent read on how...

IPH’s H1 2026 earnings in focus IPH (ASX:IPH) has put its latest half on the table with H2 2025 revenue of A$364.6 million and basic EPS of A$0.12, setting the scene for investors weighing up how the business is tracking into H1 2026 on a trailing 12 month view. The company has seen revenue move from A$332.1 million in H2 2024 to A$341.6 million in H1 2025 and then A$364.6 million in H2 2025. Over the same periods, basic EPS went from A$0.16 to A$0.14 and then A$0.12. With trailing 12 month...

On 11 February 2026, Neuren Pharmaceuticals Limited (ASX:NEU) announced a share repurchase program authorizing the buyback and cancellation of up to 6,350,631 shares, or 5% of its 126,639,526 issued shares, with the program running until 2 March 2027. This move reduces the future share count relative to current levels, which can increase each remaining share’s claim on any future earnings and cash flows. We’ll now examine how Neuren’s decision to buy back and cancel up to 5% of its shares...

In February 2026, Computershare reported half-year sales of US$1,559.1 million, slightly lower net income of US$280.4 million, raised full-year 2026 Management EPS guidance to about 144 cps (up around 6%), and announced an ordinary franked dividend of A$0.55 per share for the six months ended December 31, 2025. The combination of higher earnings guidance, attributed to momentum across key business lines, lower interest costs and a completed share buyback, together with an increased dividend...

Lovisa earnings spark fresh look at recent share performance Lovisa Holdings (ASX:LOV) has just released half year results, with sales of A$500.65 million and net income of A$58.39 million. This has drawn fresh attention to a share price that has retreated in recent months. See our latest analysis for Lovisa Holdings. The earnings release comes after a soft patch for the shares, with a 1 day share price return of 12.8% decline and a 30 day share price return of 12.91% decline, while the 5...

nib holdings has recently announced adjustments to its 2026 health insurance premiums across Australian Residents Health Insurance and other segments, reflecting updated regulatory and market conditions. Because premiums are a core revenue lever, these changes may influence nib’s balance between growth, affordability, and claims cost control across its portfolio. We’ll now examine how these 2026 premium adjustments may affect nib holdings’ investment narrative, particularly around revenue...

FireFly Metals Ltd recently reported half-year results to December 31, 2025, reducing its net loss to A$727,000 from A$5.73 million and cutting basic loss per share from A$0.011 to A$0.0011 year-on-year. This sharp improvement in profitability metrics, while still loss-making, points to operational progress that may reshape how investors assess the company’s progress. We’ll now examine how FireFly Metals’ sharply reduced half-year loss might influence its investment narrative and future...

Mesoblast (ASX:MSB) has presented new clinical data for Ryoncil to transplant specialists, reporting consistently high survival outcomes in steroid refractory acute graft versus host disease across multiple patient groups. See our latest analysis for Mesoblast. The latest Ryoncil data arrives after a mixed price run, with Mesoblast’s 90 day share price return of 4.76% contrasting with a 12.64% decline year to date and a three year total shareholder return of 164.49%. This suggests long term...